Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Las Vegas Sands Corp. (LVS.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-02-2842.8653.00Buy
2022-03-2138.6947.00Buy
2022-04-2734.8444.00Buy
2022-06-1330.6042.00Buy
2022-08-1036.6544.00Buy
2022-11-0138.6446.00Buy
2023-01-2658.3767.00Buy
2023-05-1860.6473.00Buy
2023-07-2155.9774.00Buy
2023-08-3154.8670.00Buy
2023-10-2747.0471.00Buy
2023-11-1549.2877.00Buy
2024-01-1649.0472.00Buy
2024-01-2550.1574.00Buy
2024-04-0153.1876.00Buy
2024-07-2939.5570.00Buy
2024-08-2340.6049.00Neutral
2024-10-2953.3950.00Neutral
2024-11-2250.0851.00Neutral
2025-02-0344.9352.00Neutral
2025-04-3036.6743.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.